Ordinary Share Capital Changement Date
Acadia Pharmaceuticals USD 16K 0 2023-12
Aceragen USD 8K 4K 2023-03
Agios Pharmaceuticals USD 72K 0 2023-12
Alnylam Pharmaceuticals USD 1.26M 4K 2023-12
Amgen USD 32.75B 152M 2023-09
Biogen USD 100K 0 2023-12
BioMarin Pharmaceutical USD 189K 1000 2023-12
Bluebird Bio USD 1.07M 6K 2023-09
Bristol-Myers Squibb USD 292M 0 2023-09
Eli Lilly USD 593.6M 0 2023-09
Exelixis USD 311K 9K 2023-09
Gilead Sciences USD 1000K 0 2023-09
Incyte USD 224K 0 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
Lumos Pharma USD 79K 1000 2023-09
Merck USD 1.79B 0 2023-09
Moderna USD 38.2K 100 2023-12
Nektar Therapeutics USD 19K 0 2023-09
Neurocrine Biosciences USD 100K 0 2023-09
Novartis USD 825M 17M 2023-09
Pfizer USD 478M 0 2023-09
PTC Therapeutics USD 75K 0 2023-12
Regeneron Pharmaceuticals USD 102K 0 2023-09
Sarepta Therapeutics USD 9K 0 2023-09
Ultragenyx Pharmaceutical USD 72K 1000 2023-09
Vertex Pharmaceuticals USD 2.6M 0 2023-09



Incyte Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.